WO2006016145A1 - A disinfectant formulation - Google Patents

A disinfectant formulation Download PDF

Info

Publication number
WO2006016145A1
WO2006016145A1 PCT/GB2005/003123 GB2005003123W WO2006016145A1 WO 2006016145 A1 WO2006016145 A1 WO 2006016145A1 GB 2005003123 W GB2005003123 W GB 2005003123W WO 2006016145 A1 WO2006016145 A1 WO 2006016145A1
Authority
WO
WIPO (PCT)
Prior art keywords
solution
pack system
acid
pack
salt
Prior art date
Application number
PCT/GB2005/003123
Other languages
French (fr)
Inventor
Vincent Brian Croud
Elizabeth Anne Nicol
Original Assignee
Antec International Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0417979A external-priority patent/GB0417979D0/en
Priority claimed from GB0428351A external-priority patent/GB0428351D0/en
Application filed by Antec International Limited filed Critical Antec International Limited
Priority to CA002580440A priority Critical patent/CA2580440A1/en
Priority to EP05794167A priority patent/EP1781100A1/en
Publication of WO2006016145A1 publication Critical patent/WO2006016145A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/16Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group; Thio analogues thereof

Definitions

  • a peroxyacid precursor is reacted with a peroxide source, usually hydrogen peroxide.
  • a peroxide source usually hydrogen peroxide.
  • peroxide precursors molecules containing groups such as amides (including lactams), acyl halides, or esters - particularly gem-diesters, but also including lactones - can be named.
  • activators molecules containing groups such as amides (including lactams), acyl halides, or esters - particularly gem-diesters, but also including lactones - can be named.
  • Such a system will normally not be in an equilibrium state and the rate of peroxyacid generation will depend on, amongst other things, the concentration of the reactants and their reactivity.
  • the solution thus provided yields the peroxyacid rapidly at the desired concentration for the particular disinfection treatment being undertaken.
  • the structuring electrolyte is preferably citric acid or an alkali metal salt thereof and is present in sufficient quantity to maintain the activator, where solid in suspension.
  • Levels of structuring electrolyte of 7-12% w / w of the second solution have been found to be particularly suitable and preferably of 9-11% w / w.
  • the first solution includes an organic diol.
  • the diol enables higher concentration solutions of borates to be achieved.
  • the diol is particularly advantageously a cis - 1, 2 - diol, or a -1, 3- diol which can bond more readily with borate.
  • Suitable diols for consideration are sorbitol, mannitol, xylitol, gluconic acid or salt thereof, dextrins, maltoses etc.
  • the diol is conveniently present at a level of from 0.5% to 2% w / w .
  • the ratio of first solution to second solution is preferably between 1 :3 and 3: 1 by volume, and particularly preferably 1 : 1.
  • the invention also includes a two pack system for use in disinfecting surfaces, the system including a first pack comprising hydrogen peroxide at a concentration of up to 8% w /w, an alkali metal borate salt, and a peroxide stabiliser, the second pack comprising an activator reactable with hydrogen peroxide to form a peroxyacid; a structuring electrolyte, the second pack having a pH of from 6 to 10.

Abstract

A disinfectant system is supplied in two packs, which when mixed together and diluted provides a disinfectant solution having the active peroxyacid disinfectant present at a suitable level. The system includes a first pack having a pH of from 7-9.5 and containing hydrogen peroxide, an alkali metal borate salt, and a peroxide solution. The second pack having a pH of from 6-10, has an activator - which reacts with hydrogen peroxide to generate the peroxyacid - a structuring electrolyte and a surfactant. Suitable ratios of first to second pack suitable are from 1:100 to 100:1 by weight. A corrosion inhibitor is included where the disinfectant is to be used in respect of metal surfaces. In order to activate the borate a diol containing compound is included which engages with the borate and assists in its solubilisation.

Description

A DISINFECTANT FORMULATION
Field of the Invention
The present invention relates to a disinfectant system for use, for example, in human and animal health applications. The system contemplates in-situ generation of an organic peroxyacid to function as disinfectant.
Background to the Invention
Disinfectants are becoming more widely used in an increasing number of industries. Amongst the reasons for the increasing use is the need to comply with more stringent Health and Safety Regulations as well as the fact that the number of organisms resistant to certain disinfectants is increasing. Much research in this technical area is concerned with finding more active means of disinfection, usually chemical. Amongst the problems with such active chemical disinfectants, one which is particularly difficult to overcome is the long-term stability of the disinfectant. Often the chemical groups of a molecule which make it an effective disinfectant, are the groups which make the molecule inherently unstable.
One class of molecules which is widely recognised as including fairly aggressive disinfectants, is that of the organic peroxyacids. In recent years research has been directed at these compounds, aimed not least in providing a stable and safe means of their delivery. Amongst the peroxyacids, the one which has been the subject of closest attention has been peroxyacetic acid (often referred to as peroxyacetic acid or PAA). This particular peroxyacid is rarely isolated and is normally encountered in solution in both aqueous and non-aqueous media. Peroxyacetic acid is often supplied as an equilibrium mixture including primarily water, acetic acid and hydrogen peroxide, together with a number of other minor components such as stabilisers. However, even equilibrium systems of peroxyacetic acid are inherently thermodynamically unstable due to the decomposition of peroxyacetic acid into acetic acid and oxygen. Such decomposition can be slowed down if special measures are taken but cannot be completely prevented.
A further property of peroxyacids which makes them difficult to use or store is that they can decompose rapidly and violently, particularly peroxyacids of low molecular weight and of high purity.
Because of the above it is often difficult to provide a particular concentration of peroxyacid required. In order to get around this problem, peroxyacids are often generated in-situ to perform the particular desired function. Such in-situ generation has advantages in that the amount of peroxyacid produced can be controlled through control of the starting materials and also the consumption of starting materials is optimised. Moreover, higher concentrations of peroxyacid can be achieved than are available from equilibrium systems due to the non- equilibrium nature of the in-situ systems.
Typically, in order to generate the peroxyacid, a peroxyacid precursor is reacted with a peroxide source, usually hydrogen peroxide. As examples of peroxyacid precursors (often referred to as activators), molecules containing groups such as amides (including lactams), acyl halides, or esters - particularly gem-diesters, but also including lactones - can be named. Such a system, as indicated above, will normally not be in an equilibrium state and the rate of peroxyacid generation will depend on, amongst other things, the concentration of the reactants and their reactivity.
However, it is often necessary, particularly if rapid generation of the peroxyacid is required, to have one or more of the reactants present in excess. Apart from being wasteful, this can lead to increased hazards, especially where high concentrations of hydrogen peroxide are present. Higher concentrations of hydrogen peroxide are not only intrinsically unsafe in themselves, but attract a more severe chemical hazard rating which has implications for the packaging and the transport of material. It is therefore of advantage to supply a system which provides in-situ peracid generation with the use of hydrogen peroxide at lower concentrations of the hydrogen peroxide. The invention described below seeks to address the above problems.
Summary of the Invention
According to the invention there is provided a method of production of a solution containing a peroxyacid, the method including the steps of mixing together a first and second aqueous solution; the first solution having a pH of from 7 to 9.5 and comprising;
hydrogen peroxide at a concentration of up to 8% w/w;
an alkali metal borate salt at a concentration of up to 5% w/w
a peroxide stabiliser; the second solution comprising;
an activator reactable with hydrogen peroxide to form a peroxyacid;
a structuring electrolyte; and
a surfactant;
the second solution having a pH of from 6 to 10;
the first and second solutions being mixed together in water in a ratio of from 1 :100 - 100:1 by weight of the first solution to the second solution.
The solution thus provided, yields the peroxyacid rapidly at the desired concentration for the particular disinfection treatment being undertaken.
The structuring electrolyte is preferably citric acid or an alkali metal salt thereof and is present in sufficient quantity to maintain the activator, where solid in suspension. Levels of structuring electrolyte of 7-12% w/w of the second solution have been found to be particularly suitable and preferably of 9-11% w/w.
The borate salt is advantageously a tetraborate and preferably has a concentration of less than 4% w/w of the first solution.
The surfactant can advantageously be a nonionic or an anionic surfactant or a mixture thereof. The nonionic surfactant is particularly advantageously a fattyalcoholethoxylate or polyethoxylate with preferably 12-15 carbon atoms in the chain. The anionic surfactant is particularly advantageously an organosulphonic acid or salt thereof such as an alkylbenzenesulphonate, for example dodecylbenzenesulphonic acid.
Preferably the peroxide stabiliser is added at a level sufficient to sequester peroxide decomposition catalysts, for example, transition metal ions such as iron
(II), or iron (III). Typical levels of stabiliser are from 0.3 to 0.6% w/w of the first solution. The stabiliser can be chosen from one or more of groups well known in the art such as phosphates, organophosphonic acids, carboxylic acids or the alkali metal salt thereof and can include a mixture of two or more stabilisers.
The activator is preferably selected from the group which releases peroxyaceticacid on reaction with hydrogen peroxide. Exemplifying of this group are tetraacetylethylenediamine (TAED), pentaacetylglucose (PAG), N- acetylcaprolactam. More generally, sodium nonanoyloxybenzenesulphonate, (producing peroxynonanoic acid on reaction with hydrogen peroxide) ethylidenebenzoateacetate and ethylideneheptanoate acetate can be used or mixtures thereof. The activator is advantageously present at a level of from 5- 10% w/w and particularly advantageously at 7-9% w/w.
The second solution can include a corrosion inhibitor such as benzotriazole or other inhibitors known in that art. The corrosion inhibitors find particular use where the disinfection use is to include application to a metal surface, and will be present at a level of from 0.4% to 0.8% by weight of the second solution.
Advantageously, the first solution includes an organic diol. The diol enables higher concentration solutions of borates to be achieved. The diol is particularly advantageously a cis - 1, 2 - diol, or a -1, 3- diol which can bond more readily with borate. Suitable diols for consideration are sorbitol, mannitol, xylitol, gluconic acid or salt thereof, dextrins, maltoses etc. The diol is conveniently present at a level of from 0.5% to 2% w/w.
The ratio of first solution to second solution is preferably between 1 :3 and 3: 1 by volume, and particularly preferably 1 : 1.
The invention also includes a two pack system for use in disinfecting surfaces, the system including a first pack comprising hydrogen peroxide at a concentration of up to 8% w/w, an alkali metal borate salt, and a peroxide stabiliser, the second pack comprising an activator reactable with hydrogen peroxide to form a peroxyacid; a structuring electrolyte, the second pack having a pH of from 6 to 10.
A disinfectant composition comprising a non-equilibrium solution of peroxyacid and hydrogen peroxide, the composition having a pH of from 7 to 10, and including a borate salt, and a peroxide stabiliser.
Brief Description of the Drawing
The invention will now be described with reference to the accompanying drawing. In the drawing:
Figure 1 is a line plot of peroxyacetic acid generation for the systems of Table 1.
Detailed Description of the Invention
In order to provide in-situ generation of a peroxyacid, a number of problems need to be addressed. Amongst these problems are the need to prevent the components which form the peroxyacid from reacting before they are required to. There is also a need to generate the peroxyacid at the required rate: too slow a rate can result in a lack of performance and too high a rate in wastage of peracid through inefficient side reactions and also possibly result in an unsafe composition.
One solution to the first problem is to provide a system in which the reaction elements are maintained separately until required. Such a solution to the problem is contemplated in the invention described herein.
In order to generate a peroxyacid, the most commonly used source of the peroxide moiety is hydrogen peroxide itself. The peroxyacid is generated through the reaction of hydrogen peroxide via a nucleophilic pathway, with an acyl containing molecule. Carboxylic acids themselves are not normally sufficiently reactive and so an activated form of acyl group is often used. Compounds which include such an activated acyl group are normally referred to as activators.
Furthermore, although the peroxide anion, HO2 ", is a relatively strong nucleophile, hydrogen peroxide itself is not. Reaction can therefore often be slow, particularly when the pH of the solution is a number of units away from the pKa value of hydrogen peroxide, which is approximately 11.
In the following, peroxyacid generation is described predominantly in relation to peroxyacetic acid. It will be appreciated that the method is applicable to other peroxyacids.
As demonstrated below, the presence of a soluble borate increases the rate at which peroxyacid is generated. Whilst not wishing to be bound by theory, it is believed that hydrogen peroxide and borate anions react together to form an anionic peroxoborate species in solution. Peroxoborate anions are better nucleophiles than hydrogen peroxide itself, and so react more readily with the activator, to generate peroxyacid at pHs of 7 to 9.5, and especially so in the more acidic solutions.
This effect is demonstrated in the following experiments which show the effect of the presence of an activating species such as borate anion as shown below. The results were obtained as follows: to a suspension of Tetraacetylethylenediamine (TAED) in deionised water, hydrogen peroxide was added rapidly with good mixing. The hydrogen peroxide and peroxyacetic acid levels were then monitored at time intervals. In Table 1, a comparison is shown for a system in which disodium tetraborate (DTB) was included, pre-mixed with the hydrogen peroxide. The hydrogen peroxide was determined by titration against cerium (IV) sulphate. The peroxyacetic acid level was determined by first titrating against cerium (IV) sulphate to remove hydrogen peroxide and subsequently titrating against sodium thiosulphate in the presence of potassium iodide. The results obtained are shown in Table 1 as follows:
Table 1
Figure imgf000009_0001
The pH of each system was monitored during the experiment, and the results are shown in Table 2:
Table 2
Figure imgf000009_0002
The results in Table 1 are plotted on the graph shown in Figure 1. As can be seen, the addition of disodium tetraborate increases the rate of peroxyacetic acid production for a solution having 7.5 % w/w hydrogen peroxide, to a level comparable with that obtained when 18% w/w hydrogen peroxide is present.
Further experiments, (4) and (5), were run in which N-Acetylcaprolactam was used as the activator. In order to provide the equivalent number of labile acetyl groups to generate the peroxyacetic acid, the molar concentration of N- acetylcaprolactam was twice that of the TAED in Experiments (1) - (3) above. The results are given in Table 3 below:
Table 3
Figure imgf000010_0001
The pH of each system was monitored during the experiment and the results are shown in Table 4:
Table 4
Figure imgf000010_0002
The results from Table 3, together with the results from column (3) of Table 1 are plotted in Figure 1. As can be seen from Figure 1, the presence of DTB results in a greater rate of generation of peroxyacetic acid.
In line with the above, a two component system containing TAED as activator and exemplifying the invention is as given below. The system has two aqueous compositions A and B which are constituted as follows: Composition A
69.85% w/w Deionised Water 7.1% w/w p-dodecylbenzensulphonic acid 0.60% w/w Benzotriazole
0.85% w/w Sodium Hydroxide
0.01% 7W Diethylenetriamine(pentamethylenephosphonicacid)
4.0 % w/w Isodecylalcohol ethoxylate
10.1% 7W Trisodium Citrate 0.004% FD & C Green Dye
Figure imgf000011_0001
Composition A is a structured liquid having a pH of around 7.
Composition B
3.10% 7W Disodium Tetraborate 88.80% w/wDeionised Water
0.50% w/w Diethylenetriamine(pentamethylenephosphonicacid) 7.00% 7W Hydrogen Peroxide
0.60% 7W Sodium Hydroxide
When devising a system to generate a peroxyacid it is important that the constituent parts of the compositions do not separate out, so that the chemical make up of the composition remains consistent throughout the composition during storage. This is particularly relevant for the composition containing the borate, as the aqueous solubility of the borate - for example, disodium tetraborate - is not particularly high, with the result that insoluble material can easily be present if the overall concentration of borate in the composition became too high. As the borate salts are relatively dense they would not easily form into a stable suspension, and so the solid borate would settle out.
The user therefore has two obvious problems in using a two pack system as herein contemplated. Firstly, the user will not be certain of delivering the correct amount of borate or peroxoborate species into the mixed composition, as a significant proportion of the borate species will have settled to the bottom of the pack. The amount and rate of generation of peroxyacetic acid will therefore be inconsistent between batches. Secondly, even if agitation of the borate-containing composition is undertaken prior to its being mixed with the other composition, the production of peroxyacetic acid is slowed down. The slowing is due to the introduction of a dissolution step in which the borate dissolves, prior to conversion of borate to peroxoborate. The time required to reach a required concentration of peroxyacetic acid will therefore be longer.
In order to overcome this problem therefore, it has been found advantageous to include a dissolution aid, often in the form of a diol. The diol undergoes a dehydration reaction with the hydroxy groups of the borate. The resultant species is more soluble than the original borate, effectively rendering a higher concentration borate solution, but does not, surprisingly, decrease the reactivity with hydrogen peroxide to form peroxoborate solutions. Such an increased concentration of borate species therefore increases the equilibrium concentration of peroxoborate species in solution. As a result, on mixing the borate-containing composition with the composition containing the activator, peroxyacetic acid generation is more rapid. Moreover, less of the two compositions is required to achieve a given peroxyacetic acid concentration inside a given time-scale.
The effect of a number of diols on the solubility of disodium tetraborate is shown in the following table:
Table 5: Solubility of Disodium Tetraborate in a Solution.
Figure imgf000012_0001
Table 5 shows the number of moles of disodium tetraborate which can be dissolved in a Standard volume of the particular solution before the solution becomes saturated. As can be seen from the results, a higher concentration of tetraborate can be achieved in the presence of a molecule having a diol group.
Similar remarks concerning settling of solid components may also be applied to the solution containing the activator where the activator is present as a solid. It is important therefore that the activator be prevented or hindered from settling out. To this end a structuring agent, such as citric acid or a salt thereof is included in the solution. Without being bound by theory it is believed that the structuring agent causes ordering of the water and other constituents of the solution into a structure capable of supporting the solid components. A suitable concentration for the structuring agent is from 7-12% w/wand preferably 9-11% w/w.
The following example gives an illustration of a composition suitable for use:
Example 1
A first composition C was prepared by mixing together the following:
Tetraacetylethylenediamine (TAED) 8.50% w/w. Dodecylbenzenesulphonic acid 6.95% w/w.
C10 - Fattyalcohol Ethoxylate 3.98% w/w.
Sodium Hydroxide (47% w/w) 1.92% w/w.
Trisodium Citrate (40% w/w) 24.82% w/w.
Benzotriazole 0.60% w/w. Deionised Water 53.23% w/w.
The overall composition formed was a white suspension having a pH of approximately 8. As examples of commercially available anionic surfactants, para - dodecylbenzenesulphonic acid, with minor amounts of Cio - CB secondary alkylbenzenesulphonic acids, can be cited. A suitable fattyalcohol ethoxylate is one derived from an isodecylalcohol with minor amounts of Ci2 - C15 alcohols.
A second composition D was prepared by mixing together the following:
Hydrogen Peroxide (35% w/w) 21.53% w/w. Diethylenetriamine(pentamethylenephosphonicacid) 0.33% w/w.
Disodium Tetraborate 4.06% w/w.
Sorbitol 1.27% w/w. Sodium Hydroxide (47% w/w) 2.00% w/w.
Deionised Water 70.81% w/w.
The diethylenetriaminepenta(methylenephosphonic acid) is normally supplied as its sodium salt solution (32% as sodium salt). The second composition was a clear solution having a pH of approximately 9.
The preparation of the second composition itself took place in three stages. Firstly, a solution of the sorbitol was prepared containing the following:
Sorbitol 1.82% w/w.
Disodium Tetraborate 5.80% w/w.
Diethylenetriamine(pentamethylenephosphonicacid) 0.60% w/w. Deionised Water 91.78% w/w.
A sodium hydroxide solution was also prepared containing the following:
Sodium Hydroxide (pearl) 47.00% w/w.
Diethylenetriamine(pentamethylenephosphonicacid) 0.60% w/w.
Deionised Water 52.40% w/w.
The sorbitol solution and the sodium hydroxide solution were then mixed with the other constituents shown for composition D in the following amounts to form composition D.
Sorbitol Solution 70.00% w/w.
Diethylenetriamine(pentamethylenephosphonicacid)
0.60% w/w.
Hydrogen Peroxide (35% w/w) 22.10% w/w.
Sodium Hydroxide solution 2.00% w/w. Deionised Water to 100% w/w. On mixing composition C (17ml) with composition D (17ml) in 1 litre of water, a solution containing approximately 0.1%w/w peroxyacetic acid was generated after 10 minutes.
In the above composition, benzotriazole has been included as a corrosion inhibitor. Such corrosion inhibitors would normally be used in, for example, instrument sterilisation in hospitals, where they reduce pitting of metal instruments. For other uses, such as animal health, the corrosion inhibitor can be dispensed with and so not included in the compositions.
In addition to or in place of benzotriazole, other corrosion inhibitors may also be present. For example, the benzotriazole may contain one or more substituents on either the benzene ring or on one or more of the nitrogens of the triazole group. As examples of such substituents are lower alkyl groups having up to six carbon atoms, carboxy groups, hydroxy groups, or combinations thereof. Further examples of corrosion inhibitors include alkali metal borates, phosphates or polyphosphates, sodium molybdate, benzoic acid or salts thereof.
As indicated above, the activator is included as a source of peracid precursor. A number of other activators known in the art, can also be used therefore either alone or in combination with TAED or other such activators. For example, oxybenzenesulphonic acid, such as nonanoyloxybenzenesulphonic acid, or the salts thereof can be used. Also to be considered are N-acylcaprolactams or N- acylvalerolactams such as N-acetylcaprolactam. Further well known examples of peracid precursors suitable for use are pentaacetylglucose or N,N,N,N- tetraacetylglycoluril (TAGU).
Similarly, the diol can be chosen to achieve the desired concentration of borate in solution. Amongst the diols, -1,2-diols are particularly suitable as they are stereochemically in the correct configuration to form a borate ester. However, - 1,3- ; -1,4 - and other diols can also be used. Moreover, polyhydroxy molecules can also function in the same manner as diols themselves, through the use of two of their hydroxy groups to engage with the borate molecule. Exemplary of diol-containing molecules are fructose, galactose, glucose, mannose, ribose, erythrose, lactose, sucrose, saccharose, sorbitol, xylitol, xylulose, glycerol, glycerol monoalkyl ether, gluconic acid, galactonic acid, mannonic acid, glucuronic acid, dextrins, maltoses or a cellobiose.
In addition to or in combination with
Diethylenetriamineφentamethylenephosphonicacid), other chelating agents, to stabilise peroxide, can be included in the compositions. As examples, only, of such chelating agents are other alkylideneaminophosphonic acids or salts thereof, some of which are marketed under the name Dequest . Exemplary thereof are 1- hydroxyethylidene-1 , 1 -diphosphonic acid, 1 -amino- 1 -cyclohexylmethane- 1,1- diphosphonic acid, 1 -amino- 1-phenylmethanediphosphonic acid, amino (trimethylenephosphonic acid), dimethylaminomethanediphosphonic acid, and 1- hexamethylenediaminetetra(methylenephosphonic) acid. A further class of compounds suitable for use are the aminocarboxylicacids or salts thereof. As examples, only, of members of this class are ethylenediaminetetraacetric acid, nitrilotriacetic acid, ethylenediaminedisuccinic acid, diethylenetriaminopentaa- cetic acid, N-di(methylenephosphonic acid)-aminoacetic acid.
In addition, also, suitable as chelating agents are dipicolinic acid, ethane-1, 1,2- triphosphonic acid, ethylidene- 1,1 -diphosphonic acid, phosphono-succinic acid, 1- phosphono-lmethylsuccinic acid. Furthermore, also well known in the art as chelating agents are phosphates, polyphosphates and pyrophosphates of monovalent cations, primarily sodium. Also polymeric carboxylates such as polyacrylic acid or salts thereof can also function as chelating agents. The stabiliser or stabilisers should be present in sufficient amounts to inhibit breakdown of hydrogen peroxide to allow the solutions to be stored. Levels of stabiliser of 0.3-0.6% w/w have been found to be suitable for this purpose.
In addition to or in combination with the anionic surfactant p- dodecylbenzensulphonic acid exemplified, other anionic surfactants can be included in the compositions. Amongst these are alkyl-, aryl-, alkylaryl- or arylalkyl-, sulphates or sulphonates having from 6 to 22 carbon atoms, usually present as their alkali metal salt, such as sodium laurylsulphonate or sodium laurylsulphate. Also suitable are ether sulphates or sulphonates containing alkyl-, aryl-, alkylaryl- or arylalkyl- sulphonic acids or alkali metal salts thereof. As commercially available examples of such anionic surfactants are linear alkylbenzenesulphonates under the name NANSA™ from Albright and Wilson, or HOSTAPUR™ from Hoechst. Other suitable anionic surfactants are for example naphthalenesulphonic acid, alkylnaphthalene sulphonic acids, or alkali metal salts thereof.
A further group of anionic surfactants which are suitable for use are alkylether sulphates. One subgroup thereof is the alkyl(ethylether)sulphates characterised by the general formula R2-O-(Cm H2mO)n - SO3M in which:
R2 is an alkyl group, preferably having 12-18 carbon atoms; m = 2 n = l-10
M is an alkali metal, ammonium, substituted ammonium ion, but is preferably sodium.
As further examples of anionic surfactants the class derived from sarcosine can be named.
Whilst borate is the anion of choice, other inorganic anions which are suitable are phosphates and sulphates.
It will of course be understood that the invention is not limited to the specific details described herein, which are given by way of example only, and that various modifications and alterations are possible with the scope of the appended claims.

Claims

1. A method of production of a solution containing a peroxyacid, the method including the steps of mixing together a first and second aqueous solution; the first solution having a pH of from 7 to 9.5 and comprising;
hydrogen peroxide at a concentration of up to 8% w/w;
an alkali metal borate salt at a concentration of up to 5% w/w
a peroxide stabiliser;
the second solution comprising:
an activator reactable with hydrogen peroxide to form a peroxyacid;
a structuring electrolyte; and
a surfactant;
the second solution having a pH of from 6 to 10;
the first and second solutions being mixed together in water in a ratio of from 1 : 100 - 100: 1 by weight of the first solution to the second solution.
2. A method according to Claim 1, wherein the activator is present as a solid.
3. A method according to Claim 2, wherein the structuring electrolyte is present in a sufficient quantity to maintain the solid in suspension.
4. A method according to any preceding claim wherein the structuring electrolyte is citric acid or an alkali metal salt thereof.
5. A method according to Claim 1 wherein the level of structuring electrolyte is from 7-12%w/w of the second solution.
6. A method according to Claim 5 wherein the level is from 9-11% w/w.
7. A method according to Claims 1 to 6, wherein the borate salt is a tetraborate.
8. A method according to any preceding claim wherein the borate salt has a concentration of less than 4% w/w of the first solution.
9. A method according to any preceding claim wherein the surfactant is either a nonionic, an anionic surfactant or a mixture thereof.
10. A method according to Claim 9, wherein the nonionic surfactant is a fattyalcoholethoxylate or fattyalcoholpolyethoxylate.
11. A method according to Claim 10 wherein the fattyalcoholpolyethoxylate has 12- 15 carbon atoms in the chain.
12. A method according to Claim 11, wherein the anionic surfactant is an organosulphonic acid or salt thereof.
13. A method according to Claim 12, wherein the anionic surfactant is an alkylbenzenesulphonic acid or salt thereof.
14. A method according to Claim 13, wherein the alkylbenzenesulphonic acid is dodecylbenzenesulphonic acid or salt thereof.
15. A method according to any preceding claim wherein the peroxide stabiliser is at a level sufficient to sequester peroxide decomposition catalysts.
16. A method according to Claim 15 wherein the stabiliser is present at a level of from 0.3 to 0.6% w/wof the first solution.
17. A method according to any preceding claim wherein the stabiliser is selected from one or more molecules containing one or more of a phosphate, organophosphonic
5 acid, carboxylic acid groups or the alkali metal salt thereof.
18. A method according to Claim 16, wherein the stabiliser comprises a mixture of two or more peroxide stabilisers.
10 19. A method according to any preceding claim wherein the activator releases peroxyacetic acid on reaction with hydrogen peroxide.
20. A method according to any preceding claim, wherein the activator is selected from, tetraacetylethylenediamine, pentaacetylglucose, or N-acetylcaprolactam.
15
21. A method according to Claims 1 - 18 wherein the activator is selected from, sodium nonanoyloxybenzenesulphonate, ethylidenebenzoateacetate and ethylideneheptanoate acetate.
10 22. A method according to any preceding claim wherein the second solution includes a corrosion inhibitor.
23. A method according to Claim 22 wherein the corrosion inhibitor is benzotriazole.
15 24. A method according to either of Claims 22 or 23, wherein the inhibitor is present at a level of from 0.4 to 0.8% by weight of the second solution.
25. A method according to any preceding claim wherein the activator is present at a level of from 5-10% by weight of the second solution.
50
26. A method according to Claim 25, wherein the activator is present at a level of from
7-9% 7w.
27. A method according to any preceding claim, wherein the first solution includes an S 5 organic compound having at least two hydroxy alcohol groups.
28. A method according to Claim 27, wherein the organic compound includes a cis - 1, 2 - diol, or a -1, 3- diol group.
29. A method according to Claim 28, wherein the diol containing molecule is selected from a dextrin, a maltose, sorbitol, mannitol, xylitol, gluconic acid or salt thereof.
30. A method according to Claim 29, wherein the diol is present at a level of from 0.5% to 2% w/w
31. A method according to any preceding claim, wherein the ratio of first solution to second solution is between 1 :3 and 3 : 1 by volume.
32. A method according to Claim 31 , wherein the ratio is 1 : 1.
33. A two pack system for use in disinfecting surfaces, the system including a first pack including a solution having a pH of from 7 to 9.5 and comprising hydrogen peroxide at a concentration of up to 8% w/w, an alkali metal borate salt, at a concentration of up to 5% w/w and a peroxide stabiliser, the second pack including a solution having a pH of from 6 to 10 and comprising an activator reactable with hydrogen peroxide to form a peroxyacid; and a structuring electrolyte.
34. A two pack system according to Claim 33, wherein the activator is present as a solid.
35. A two pack system according to Claim 34 wherein the structuring electrolyte is present in a sufficient quantity to maintain the solid in suspension.
36. A two pack system according to any of claims 33-35, wherein the structuring electrolyte is citric acid or an alkali metal salt thereof.
37. A two pack system according to any of claims 33-36, wherein the level of structuring electrolyte is from 7-12% w/wof the solution in the second pack.
38. A two pack system according to Claim 37, wherein the level of electrolyte is from 9-11% w/w.
39. A two pack system according to any of claims 33-38, wherein the borate salt is a tetraborate.
40. A two pack system according to any of claims 33-39, wherein the borate salt has a concentration of less than 4% w/wof the solution in the first pack.
41. A two pack system according to any of claims 33-40, wherein the surfactant is either a nonionic, an anionic surfactant or a mixture thereof.
42. A two pack system according to Claim 41, wherein the nonionic surfactant is a fattyalcoholethoxylate or fattyalcoholpolyethoxylate.
43. A two pack system according to Claim 42, wherein the fattyalcoholpolyethoxylate has 12-15 carbon atoms in the claim.
44. A two pack system according to Claim 41, wherein the anionic surfactant is an organosulphonic acid or salt thereof.
45. A two pack system according to Claim 44, wherein the anionic surfactant is an alkylbenzenesulphonic acid or salt thereof.
46. A two pack system according to Claim 45, wherein the anionic surfactant is dodecylbenzenesulphonic acid or salt thereof.
47. A two pack system according to any of claims 33-46, wherein the stabiliser is present at a level from 0.3 - 0.6% w/wof the solution of the first pack.
48. A two pack system according to any of claims 33-47, wherein the stabiliser is selected from one or more molecules containing one or more of a phosphate, organophosphonic acid, carboxylic acid groups or the alkali metal salt thereof.
49. A two pack system according to any of claims 33-48, wherein the activator is selected from tetracetylethylenediamine, pentaacetylglucose or N-acetylcaprolactam.
50. A two pack system according to any of claims 33-48, wherein the activator is selected from sodium nonanoyloxybenzenesulphate, ethylidenebenzoateacetate, or ethylideneheptanoate acetate.
51. A two pack system according to any of claims 33-50, wherein the solution of the second pack includes a corrosion inhibitor.
5
52. A two pack system according to Claim 51, wherein the corrosion inhibitor is benzotriazole.
53. A two pack system according to either of Claims 5 lor 52, wherein the corrosion [0 inhibitor is present at a level of from 0.4 - 0.8% 7W of the solution of the second pack.
54. A two pack system according to any of Claims 33-53, wherein the activator is present at a level of from 5-10% w/wof the second solution.
[5
55. A two pack system according to Claim 54, wherein the activator is present at a lavel
Figure imgf000023_0001
50 56. A two pack system according to any of claims 33-55, wherein the solution of the first pack includes an organic compound having at least two hydroxy alcohol groups.
57. A two pack system according to Claim 56, wherein the organic compound includes a cis-l,2-diol or a -l,3-diol group.
15
58. A two pack system according to Claim 57, wherein the diol containing molecule is selected from a dextrin, a maltose, sorbitol, mannitol, xylitol, gluconic acid or salt thereof.
i0 59. A two pack system according to Claim 58, wherein the diol containing molecule is present at a level of from 0.5% to 2% 7W.
60. A disinfectant composition comprising a non-equilibrium solution of peroxyacid and hydrogen peroxide, the composition having a pH of from 7 to 10, and including a !5 borate salt, and a peroxide stabiliser.
PCT/GB2005/003123 2004-08-12 2005-08-08 A disinfectant formulation WO2006016145A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002580440A CA2580440A1 (en) 2004-08-12 2005-08-08 A disinfectant formulation
EP05794167A EP1781100A1 (en) 2004-08-12 2005-08-08 A disinfectant formulation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0417979.2 2004-08-12
GB0417979A GB0417979D0 (en) 2004-08-12 2004-08-12 A disinfection formulation
GB0428351A GB0428351D0 (en) 2004-12-24 2004-12-24 A disinfectant formulation
GB0428351.1 2004-12-24

Publications (1)

Publication Number Publication Date
WO2006016145A1 true WO2006016145A1 (en) 2006-02-16

Family

ID=35229736

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2005/003123 WO2006016145A1 (en) 2004-08-12 2005-08-08 A disinfectant formulation

Country Status (5)

Country Link
EP (1) EP1781100A1 (en)
AR (1) AR050782A1 (en)
CA (1) CA2580440A1 (en)
TW (1) TW200618737A (en)
WO (1) WO2006016145A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011017095A2 (en) 2009-07-27 2011-02-10 E. I. Du Pont De Nemours And Company Enzymatic in situ preparation of peracid-based removable antimicrobial coating compositions and methods of use
WO2011017087A2 (en) 2009-07-27 2011-02-10 E. I. Du Pont De Nemours And Company In situ preparation of peracid-based removable antimicrobial coating compositions and methods of use
US8034766B2 (en) 2006-10-27 2011-10-11 E I Du Pont De Nemours And Company Compositions and methods for prion decontamination
CN102964285A (en) * 2012-11-28 2013-03-13 北京红辉力上科技有限公司 Peroxyacetic acid generator and preparation method thereof
EP2095714A3 (en) * 2008-02-26 2013-06-05 Mondial S.N.C. di Cavinato Antonio & C. Disinfecting and cold-sterilizing solution
US8729296B2 (en) 2010-12-29 2014-05-20 Ecolab Usa Inc. Generation of peroxycarboxylic acids at alkaline pH, and their use as textile bleaching and antimicrobial agents
WO2014089632A1 (en) * 2012-12-14 2014-06-19 Saban Ventures Pty Limited Synergistic disinfection enhancement
US9321664B2 (en) 2011-12-20 2016-04-26 Ecolab Usa Inc. Stable percarboxylic acid compositions and uses thereof
US9763442B2 (en) 2010-12-29 2017-09-19 Ecolab Usa Inc. In situ generation of peroxycarboxylic acids at alkaline pH, and methods of use thereof
US9926214B2 (en) 2012-03-30 2018-03-27 Ecolab Usa Inc. Use of peracetic acid/hydrogen peroxide and peroxide-reducing agents for treatment of drilling fluids, frac fluids, flowback water and disposal water
US10031081B2 (en) 2013-03-05 2018-07-24 Ecolab Usa Inc. Peroxycarboxylic acid compositions suitable for inline optical or conductivity monitoring
US10165774B2 (en) 2013-03-05 2019-01-01 Ecolab Usa Inc. Defoamer useful in a peracid composition with anionic surfactants
US10206404B2 (en) 2012-12-14 2019-02-19 Saban Ventures Pty Limited Disinfectant
US10893674B2 (en) 2013-03-05 2021-01-19 Ecolab Usa Inc. Efficient stabilizer in controlling self accelerated decomposition temperature of peroxycarboxylic acid compositions with mineral acids

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114145296A (en) * 2020-12-24 2022-03-08 北京普朗宁生物科技有限公司 Peroxyacetic acid liquid generating agent and using method thereof
CN115015435B (en) * 2022-06-30 2024-03-22 山东新华医疗器械股份有限公司 Method for detecting N-acetyl caprolactam in disinfectant

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2377038A (en) * 1941-09-15 1945-05-29 Du Pont Manufacture of peracids
EP0488090A1 (en) * 1990-11-30 1992-06-03 Solvay Interox GmbH Stable and solid acetylperoxyborate compounds
US20040176267A1 (en) 2003-01-06 2004-09-09 Hobson David W. Organic peroxyacid precursors
CN1542000A (en) * 2003-04-28 2004-11-03 浙江金科化工有限公司 A solid generating agent for preparing peroxy acetic acid

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2377038A (en) * 1941-09-15 1945-05-29 Du Pont Manufacture of peracids
EP0488090A1 (en) * 1990-11-30 1992-06-03 Solvay Interox GmbH Stable and solid acetylperoxyborate compounds
US20040176267A1 (en) 2003-01-06 2004-09-09 Hobson David W. Organic peroxyacid precursors
CN1542000A (en) * 2003-04-28 2004-11-03 浙江金科化工有限公司 A solid generating agent for preparing peroxy acetic acid

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 200518, Derwent World Patents Index; Class D22, AN 2005-163885, XP002353798 *
HASHEM, BULL. NRC, EGYPT, vol. 26, no. 2, 2001, pages 169 - 83
HASHEM, M.M.: "Low temperature bleaching of flax fibers with peracetic acid", BULLETIN OF THE NATIONAL RESEARCH CENTRE, vol. 26, no. 2, 2001, Egypt, pages 169 - 183, XP009057006, ISSN: 1110-0591 *

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034766B2 (en) 2006-10-27 2011-10-11 E I Du Pont De Nemours And Company Compositions and methods for prion decontamination
US8431526B2 (en) 2006-10-27 2013-04-30 E. I. Du Pont De Nemours And Company Compositions and methods for prion decontamination
EP2095714A3 (en) * 2008-02-26 2013-06-05 Mondial S.N.C. di Cavinato Antonio & C. Disinfecting and cold-sterilizing solution
WO2011017087A2 (en) 2009-07-27 2011-02-10 E. I. Du Pont De Nemours And Company In situ preparation of peracid-based removable antimicrobial coating compositions and methods of use
WO2011017095A2 (en) 2009-07-27 2011-02-10 E. I. Du Pont De Nemours And Company Enzymatic in situ preparation of peracid-based removable antimicrobial coating compositions and methods of use
US9763442B2 (en) 2010-12-29 2017-09-19 Ecolab Usa Inc. In situ generation of peroxycarboxylic acids at alkaline pH, and methods of use thereof
US10477862B2 (en) 2010-12-29 2019-11-19 Ecolab Usa Inc. In situ generation of peroxycarboxylic acids at alkaline pH, and methods of use thereof
US8729296B2 (en) 2010-12-29 2014-05-20 Ecolab Usa Inc. Generation of peroxycarboxylic acids at alkaline pH, and their use as textile bleaching and antimicrobial agents
US9321664B2 (en) 2011-12-20 2016-04-26 Ecolab Usa Inc. Stable percarboxylic acid compositions and uses thereof
US10017403B2 (en) 2012-03-30 2018-07-10 Ecolab Usa Inc. Use of peracetic acid/hydrogen peroxide and peroxide-reducing enzymes for treatment of drilling fluids, frac fluids, flowback water and disposal water
US9926214B2 (en) 2012-03-30 2018-03-27 Ecolab Usa Inc. Use of peracetic acid/hydrogen peroxide and peroxide-reducing agents for treatment of drilling fluids, frac fluids, flowback water and disposal water
US10023484B2 (en) 2012-03-30 2018-07-17 Ecolab Usa Inc. Use of peracetic acid/hydrogen peroxide and peroxide-reducing agents for treatment of drilling fluids, frac fluids, flowback water and disposal water
US11180385B2 (en) 2012-10-05 2021-11-23 Ecolab USA, Inc. Stable percarboxylic acid compositions and uses thereof
US11939241B2 (en) 2012-10-05 2024-03-26 Ecolab Usa Inc. Stable percarboxylic acid compositions and uses thereof
CN102964285A (en) * 2012-11-28 2013-03-13 北京红辉力上科技有限公司 Peroxyacetic acid generator and preparation method thereof
AU2013359955B2 (en) * 2012-12-14 2017-08-10 Saban Ventures Pty Limited Synergistic disinfection enhancement
US9789216B2 (en) 2012-12-14 2017-10-17 Saban Ventures Pty Limited Synergistic disinfection enhancement
US9872930B2 (en) 2012-12-14 2018-01-23 Saban Ventures Pty Limited Synergistic disinfection enhancement
CN104981156A (en) * 2012-12-14 2015-10-14 萨班企业私人有限公司 Synergistic disinfection enhancement
JP2016505564A (en) * 2012-12-14 2016-02-25 サバン ベンチャーズ ピーティーワイ リミテッド Synergistic disinfection enhancement
US10206404B2 (en) 2012-12-14 2019-02-19 Saban Ventures Pty Limited Disinfectant
WO2014089632A1 (en) * 2012-12-14 2014-06-19 Saban Ventures Pty Limited Synergistic disinfection enhancement
US10031081B2 (en) 2013-03-05 2018-07-24 Ecolab Usa Inc. Peroxycarboxylic acid compositions suitable for inline optical or conductivity monitoring
US11026421B2 (en) 2013-03-05 2021-06-08 Ecolab Usa Inc. Efficient stabilizer in controlling self accelerated decomposition temperature of peroxycarboxylic acid compositions with mineral acids
US10893674B2 (en) 2013-03-05 2021-01-19 Ecolab Usa Inc. Efficient stabilizer in controlling self accelerated decomposition temperature of peroxycarboxylic acid compositions with mineral acids
US11206826B2 (en) 2013-03-05 2021-12-28 Ecolab Usa Inc. Defoamer useful in a peracid composition with anionic surfactants
US10165774B2 (en) 2013-03-05 2019-01-01 Ecolab Usa Inc. Defoamer useful in a peracid composition with anionic surfactants

Also Published As

Publication number Publication date
EP1781100A1 (en) 2007-05-09
CA2580440A1 (en) 2006-02-16
TW200618737A (en) 2006-06-16
AR050782A1 (en) 2006-11-22

Similar Documents

Publication Publication Date Title
EP1781100A1 (en) A disinfectant formulation
JP2843438B2 (en) Compositions and methods of using them
JP4417563B2 (en) Process for the preparation of aqueous peroxycarboxylic acid monoester solutions, solutions obtained by this process, and their use as disinfectants
CA2275362A1 (en) Percarboxylic acid solutions
US20100021558A1 (en) Dilute Aqueous Peracid Solutions and Stabilization Method
US6254801B1 (en) Hardness-stabilizing percarboxylic acid solutions, a process for their preparation and their use
US5869440A (en) Peroxide activation method and peroxide composition
WO2016044607A1 (en) Activated disinfectant hydrogen peroxide compositions
JP2001505896A (en) How to disinfect equipment
EP1618786B1 (en) Composition for bactericide production and process for producing organic peracid
AU2021232836B2 (en) Novel peroxide stabilizers
JP2959873B2 (en) Alkaline hydrogen peroxide aqueous solution and method for stabilizing the same
EP0617697B1 (en) Alkaline hydrogen peroxide formulation
JP2009155270A (en) Replenisher for antiseptic solution for medical equipment
AU2359801A (en) Method for producing peroxycarboxylic acid solutions, especially equilibrium peracetic acid and perpropionic acid
CN111387189A (en) Disinfectant composition
JPS61134303A (en) Stabilized concentrated solution for sterilization
EP2407529A1 (en) Peroxygen composition
JPH11189789A (en) Liquid bleaching composition
NZ793746A (en) Novel peroxide stabilizers
JP2008001834A (en) Method for producing liquid detergent composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2005794167

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2580440

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2005794167

Country of ref document: EP